Salvat reports topline phase III results for combination otic solution in AOMT Oct. 3, 2014 No Comments
Phase Ib data of synthetic cis-retinoid therapy for patients with genetic retinal defects Sep. 19, 2014 No Comments
Autifony Therapeutics awarded grant to support phase IIa study of AUT-00063 for tinnitus June 10, 2014 No Comments
Close-field electroporation gene delivery for damaged cochlear hair cells regeneration May 29, 2014 No Comments
Oricula Therapeutics receives NIH grant to further develop medicine to preserve hearing May 2, 2014 No Comments
Oricula Therapeutics secures intellectual property and funding to prevent hearing loss April 10, 2014 No Comments
Amarantus acquires option to license intellectual property for MANF and CDNF March 10, 2014 No Comments